BACKGROUND: Early catheter-related infection is a serious complication in cancer treatment, although risk factors for its occurrence are not well established. The authors conducted a prospective study to identify the risk factors for developing early catheter-related infection. METHODS: All consecutive patients with cancer who underwent insertion of a central venous catheter were enrolled and were followed prospectively during 1 month. The study endpoint was occurrence of early catheter-related infection. RESULTS: Over 10,392 catheter-days of follow-up, 14 of 371 patients had early catheter-related infections (14 patients in 10,392 catheter-days or 1.34 per 1000 catheter-days). The causative pathogens were gram positive in 11 of 14 patients. In univariate analysis, the risk factors for early catheter-related infection were aged <10 years (P = .0001), difficulties during insertion (P < 10(-6)), blood product administration (P < 10(-3)), parenteral nutrition (P < 10(-4)), and use >2 days (P < 10(-6)). In multivariate analysis, 3 variables remained significantly associated with the risk of early catheter-related infection: age <10 years (odds ratio [OR], 18.4; 95% confidence interval [95% CI], 1.9-106.7), difficulties during insertion procedure (OR, 25.6; 95% CI, 4.2-106), and parenteral nutrition (OR, 28.5; 95% CI, 4.2-200). CONCLUSIONS: On the day of insertion, 2 variables were identified that were associated with a high risk of developing an early catheter-related infection: young age and difficulties during insertion. The results from this study may be used to identify patients who are at high risk of infection who may be candidates for preventive strategies.
BACKGROUND: Early catheter-related infection is a serious complication in cancer treatment, although risk factors for its occurrence are not well established. The authors conducted a prospective study to identify the risk factors for developing early catheter-related infection. METHODS: All consecutive patients with cancer who underwent insertion of a central venous catheter were enrolled and were followed prospectively during 1 month. The study endpoint was occurrence of early catheter-related infection. RESULTS: Over 10,392 catheter-days of follow-up, 14 of 371 patients had early catheter-related infections (14 patients in 10,392 catheter-days or 1.34 per 1000 catheter-days). The causative pathogens were gram positive in 11 of 14 patients. In univariate analysis, the risk factors for early catheter-related infection were aged <10 years (P = .0001), difficulties during insertion (P < 10(-6)), blood product administration (P < 10(-3)), parenteral nutrition (P < 10(-4)), and use >2 days (P < 10(-6)). In multivariate analysis, 3 variables remained significantly associated with the risk of early catheter-related infection: age <10 years (odds ratio [OR], 18.4; 95% confidence interval [95% CI], 1.9-106.7), difficulties during insertion procedure (OR, 25.6; 95% CI, 4.2-106), and parenteral nutrition (OR, 28.5; 95% CI, 4.2-200). CONCLUSIONS: On the day of insertion, 2 variables were identified that were associated with a high risk of developing an early catheter-related infection: young age and difficulties during insertion. The results from this study may be used to identify patients who are at high risk of infection who may be candidates for preventive strategies.
Authors: G Gonzalez; A M Davidoff; S C Howard; C-H Pui; B N Rao; J L Shenep; A Wozniak; S J Shochat Journal: Pediatr Blood Cancer Date: 2011-12-11 Impact factor: 3.167
Authors: Charles Ferté; Christophe Massard; Christian Moldovan; Eric Desruennes; Yohann Loriot; Jean-Charles Soria Journal: Invest New Drugs Date: 2009-02-17 Impact factor: 3.850
Authors: Natalia Curto-García; Julio García-Suárez; Marta Callejas Chavarria; Juan José Gil Fernández; Yolanda Martín Guerrero; Elena Magro Mazo; Shelly Marcellini Antonio; Luis Miguel Juárez; Isabel Gutierrez; Juan José Arranz; Irene Montalvo; Carmen Elvira; Pilar Domínguez; María Teresa Díaz; Carmen Burgaleta Journal: Support Care Cancer Date: 2015-05-03 Impact factor: 3.603
Authors: Allison Lipitz-Snyderman; Kent A Sepkowitz; Elena B Elkin; Laura C Pinheiro; Camelia S Sima; Crystal H Son; Coral L Atoria; Peter B Bach Journal: J Clin Oncol Date: 2014-06-30 Impact factor: 44.544
Authors: Eric Voog; Loïc Campion; Pauline du Rusquec; Hugues Bourgeois; Julien Domont; Fabrice Denis; Eric Emmanuel; Olivier Dupuis; Gérard Ganem; Cedrik Lafont; Katell Le Du; Elena Pavluc; Yohan Pointreau; Sophie Roche; Laurence Juhel-Voog; Marie Zinger; Philippe Solal-Celigny Journal: Support Care Cancer Date: 2017-07-29 Impact factor: 3.603
Authors: Nicolas Penel; Jean-Pierre Delord; Marie-Edith Bonneterre; Thomas Bachelot; Isabelle Ray-Coquard; Jean-Yves Blay; Laurent Benjamin Pascal; Cécile Borel; Thomas Filleron; Antoine Adenis; Jacques Bonneterre Journal: Invest New Drugs Date: 2009-02-10 Impact factor: 3.850
Authors: Allison Lipitz-Snyderman; Qinli Ma; Michael F Pollack; John Barron; Elena B Elkin; Peter B Bach; Jennifer L Malin Journal: J Oncol Pract Date: 2015-08-11 Impact factor: 3.840